› 2x4z

X-ray diffraction
2.1Å resolution

Crystal Structure of the Human p21-Activated Kinase 4 in Complex with PF-03758309

Released:
DOI: 10.2210/pdb2x4z/pdb
PDB entry 2x4z coloured by chain, front view.
PDB entry 2x4z coloured by chain, side view.
PDB entry 2x4z coloured by chain, top view.
Source organism: Homo sapiens
Primary publication:
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth.
Murray BW, Guo C, Piraino J, Westwick JK, Zhang C, Lamerdin J, Dagostino E, Knighton D, Loi CM, Zager M, Kraynov E, Popoff I, Christensen JG, Martinez R, Kephart SE, Marakovits J, Karlicek S, Bergqvist S, Smeal T
Proc Natl Acad Sci U S A 107 9446-51 (2010)
PMID: 20439741

Function and Biology Details

Reaction catalysed: 
ATP + a protein = ADP + a phosphoprotein
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
monomeric (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-132116 (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
Serine/threonine-protein kinase PAK 4 Chain: A
Molecule details ›
Chain: A
Length: 296 amino acids
Theoretical weight: 33.42 KDa
Source organism: Homo sapiens
Expression system: Escherichia coli
UniProt:
  • Canonical: O96013 (Residues: 296-591; Coverage: 50%)
Gene names: KIAA1142, PAK4
Sequence domains: Protein kinase domain
Structure domains:

Ligands and Environments

2 bound ligands:
Ligand GOL 2 x GOL
Ligand 7KC 1 x 7KC
1 modified residue:
Ligand SEP 1 x SEP

Experiments and Validation Details

Entry percentile scores
X-ray source: ALS BEAMLINE 5.0.1
Spacegroup: P212121
Unit cell:
a: 55.654Å b: 65.923Å c: 84.653Å
α: 90° β: 90° γ: 90°
R-values:
R R work R free
0.2 0.2 0.262
Expression system: Escherichia coli

Quick links

Citations

37 review citations

PAK signalling during the development and progression of cancer.
Radu et al. (2014)
36 more

11 mentions without citation

Recent advances on development of p21-activated kinase 4 inhibitors as anti-tumor agents.
Li et al. (2022)
10 more